Immunovant IMVT
NASDAQ IMVT
$34.08 +0.43 (+1.28%)
As of: Oct 2, 2026 · 9:34 AM EDT

Immunovant (IMVT) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Immunovant (IMVT) recorded Depreciation & Amortization (CF) of $92,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 14.0% from $107,000 a year earlier and down 4.2% from the prior quarter.

Analysis

Immunovant (IMVT) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

On a TTM basis, Immunovant's Depreciation & Amortization (CF) came in at $394,000 as of Jun 30, 2026, down 2.5% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $409,000, up 8.5% from FY2025.

  • Annual Depreciation & Amortization (CF) has increased for seven straight fiscal years, with a five-year compound annual growth rate of 44.5% (FY2021 to FY2026).
  • Across earlier fiscal years, Depreciation & Amortization (CF) came in at $377,000 in FY2025 (+63.2%), $231,000 in FY2024 (+19.7%), $193,000 in FY2023 (+53.2%) and $126,000 in FY2022 (+93.8%).
  • The fiscal Q1 2027 figure is the lowest quarterly Depreciation & Amortization (CF) since fiscal Q2 2025.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in six of the last eight quarters, with growth averaging 28.5%.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 100.0% in fiscal Q2 2022, against a decline of 14.0% in fiscal Q1 2027 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $96,000 (Q4 2026), $101,000 (Q3 2026) and $105,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Immunovant 6.97 Bn 6.97 Bn - 92,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 92,000.00
Mar 31, 2026 96,000.00
Dec 31, 2025 101,000.00
Sep 30, 2025 105,000.00
Jun 30, 2025 107,000.00
Mar 31, 2025 109,000.00
Dec 31, 2024 99,000.00
Sep 30, 2024 89,000.00
Jun 30, 2024 80,000.00
Mar 31, 2024 64,000.00
Dec 31, 2023 58,000.00
Sep 30, 2023 56,000.00
Jun 30, 2023 53,000.00
Mar 31, 2023 54,000.00
Dec 31, 2022 49,000.00
Sep 30, 2022 46,000.00
Jun 30, 2022 44,000.00
Mar 31, 2022 39,000.00
Dec 31, 2021 33,000.00
Sep 30, 2021 28,000.00
API Access

Immunovant Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=IMVT&period=max&api_key=YOUR_API_KEY